针对自身免疫性肺气膜蛋白质的外源性GM-CSF疗法:一个系统的文献综述
Wushu Chen1,2, Xin Feng1, Lun-Kai Yao1
1Gastroenterology and Respiratory Internal Medicine Department, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Frontiers in medicine
|May 23, 2025
概括
雾化吸入颗粒细胞 - 巨细胞殖民地刺激因子 (GM-CSF) 对于治疗自身免疫性肺气膜蛋白质症 (aPAP) 比皮下注射更有效和更安全. 在24周的每日剂量为300-400μg时,观察到最优的结果.
科学领域:
- 肺部医学 肺部医学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自身免疫性肺膜蛋白质症 (aPAP) 是一种罕见的肺部疾病.
- 颗粒细胞-巨细胞殖民地刺激因子 (GM-CSF) 是aPAP的关键疗法.
- 目前的施用方法包括皮下注射和雾化吸入,具有有限的比较数据.
研究的目的:
- 系统地审查和比较用于aPAP治疗的皮下与雾化GM-CSF的疗效和安全性.
- 为了确定雾化GM-CSF治疗的最佳剂量和持续时间.
主要方法:
- 对aPAP患者的GM-CSF治疗进行系统的文献综述.
- 分类为皮下注射组 (SIG) 和雾化吸入组 (NIG).
- 使用千平方,t测试和克鲁斯卡尔-瓦利斯H测试对治疗疗效和不良事件的统计评估.
主要成果:
- 雾化吸入 (78.3%的患者) 比皮下注射 (21.7%) 更有效 (77.3%对54.5%的疗效,P<0.001).
- 雾化GM-CSF显示出更高的有效性和更少的不良事件.
- 对雾化GM-CSF的最佳疗效是在300-400μg/天超过24周的时间内观察到.
结论:
- 在aPAP患者中,雾化吸入是一种更有效和更安全的GM-CSF给药途径.
- 对于雾化GM-CSF,建议最佳剂量为300-400μg/天,治疗持续时间超过24周.
- 这种途径在aPAP管理中比皮下注射提供了显著的优势.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
336
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
336
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:20Asthma: Pathogenesis and Management
628
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
628
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K